Raltegravir Tablet, Film Coated
Product Images NDC 31722-584

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raltegravir (NDC 31722-584). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Raltegravirtab400mglabel (Raltegravirtab400mglabel)

Raltegravirtab400mglabel (Raltegravirtab400mglabel)
Label for Raltegravir Tablets USP 400 mg film-coated tablets, packaged in a 60-count bottle by Camber Pharmaceuticals, Inc. The label includes a tablet image marked 'HI', storage instructions, a barcode, and manufacturing details mentioning Hetero Labs Limited in India.*
FDA Label Image

Raltegravirtab400mgstructure (Raltegravirtab400mgstructure)

Raltegravirtab400mgstructure (Raltegravirtab400mgstructure)
Chemical structure of raltegravir potassium, showing its molecular arrangement including rings, functional groups, and potassium ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.